"Orion on suomalainen lääkeyhtiö, joka toimii maailmanlaajuisesti. Orion kehittää, valmistaa ja markkinoi ihmis- ja eläinlääkkeitä sekä lääkkeiden vaikuttavia aineita. Orionilla on laaja valikoima perusterveydenhuollon lääkkeitä yleisimpien sairauksien hoitoon ja ehkäisyyn. Yhtiö panostaa jatkuvasti uusien lääkkeiden sekä hoitotapojen tutkimiseen sekä kehittämiseen. Orionin lääketutkimuksen ydinterapia-alueita ovat keskushermostosairaudet, syöpäsairaudet sekä hengityselinsairaudet. Hengityselinsairauksien joiden hoitoon Orion kehittää inhaloitavia Easyhaler®-keuhkolääkkeitä. Orionin asiakaskunta koostuu pääasiassa sairaanhoidon ja terveydenhuollon palveluntuottajista sekä ammattilaisista."

During the past decade, Orion Pharma phase I unit conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Orion Pharma phase I unit" are "Healthy" (3 trials), "Asthma" (2 trials) and "Parkinson's Disease" (1 trials). Many other conditions were trialed in "Orion Pharma phase I unit" in a lesser frequency.

Most popular intervention types in "Orion Pharma phase I unit" are "Drug" (6 trials). Other intervention types were less common.

The name of intervention was led by "Alprazolam" (2 trials), "Budesonide/Formoterol Batch 1" (1 trials), "Budesonide/Formoterol Batch 1 and charcoal" (1 trials), "Budesonide/Formoterol Batch 2" (1 trials) and "Budesonide/formoterol 320/9 μg and 400/12 μg inhalers" (1 trials). Other intervention names were less common.

The vast majority of trials in "Orion Pharma phase I unit" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Orion Pharma phase I unit". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Orion Pharma phase I unit, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Orion Pharma phase I unit, 6 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".